Cited by 437HIV/AIDS Research and InterventionsMedication Adherence and ComplianceHIV/AIDS Impact and Responses

Explaining Adherence Success in Sub-Saharan Africa: An Ethnographic Study

Open access
Ware, Norma C, Idoko, John, Kaaya, Sylvia, Biraro, Irene Andia, Wyatt, Monique A, Agbaji, Oche, Chalamilla, Guerino, Bangsberg, David R·2009·PLoS Medicine

Abstract

BACKGROUND: Individuals living with HIV/AIDS in sub-Saharan Africa generally take more than 90% of prescribed doses of antiretroviral therapy (ART). This number exceeds the levels of adherence observed in North America and dispels early scale-up concerns that adherence would be inadequate in settings of extreme poverty. This paper offers an explanation and theoretical model of ART adherence success based on the results of an ethnographic study in three sub-Saharan African countries. METHODS AND FINDINGS: Determinants of ART adherence for HIV-infected persons in sub-Saharan Africa were examined with ethnographic research methods. 414 in-person interviews were carried out with 252 persons taking ART, their treatment partners, and health care professionals at HIV treatment sites in Jos, Nigeria; Dar es Salaam, Tanzania; and Mbarara, Uganda. 136 field observations of clinic activities were also conducted. Data were examined using category construction and interpretive approaches to analysis. Findings indicate that individuals taking ART routinely overcome economic obstacles to ART adherence through a number of deliberate strategies aimed at prioritizing adherence: borrowing and "begging" transport funds, making "impossible choices" to allocate resources in favor of treatment, and "doing without." Prioritization of adherence is accomplished through resources and help made available by treatment partners, other family members and friends, and health care providers. Helpers expect adherence and make their expectations known, creating a responsibility on the part of patients to adhere. Patients adhere to promote good will on the part of helpers, thereby ensuring help will be available when future needs arise. CONCLUSION: Adherence success in sub-Saharan Africa can be explained as a means of fulfilling social responsibilities and thus preserving social capital in essential relationships.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pmed.1000011

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Studies on ART adherence showed that predictors and risk factors differ per region of the world.

    “Studies on ART adherence showed that predictors and risk factors differ per region of the world, necessitating context-specific development of non-adherence profiles.9 10”

    From Determinants of adherence to antiretroviral therapy among HIV-positive adults in sub-Saharan Africa: a systematic review (2016) · cites this paper as [9]

    The Discussion contrasts economic obstacles and social relationships in sub-Saharan Africa with an individual-level account of adherence in North America, and describes a theory of differences between resource-poor and resource-rich settings. This supports context-dependent influences on adherence, but the paper does not establish that predictors and risk factors differ across regions of the world generally. The call for context-specific non-adherence profiles is the citing authors’ inference, not a finding reported in this paper. (LLM, conf=0.83)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 46

  1. Oyugi JH Byakika-Tusiime J Charlebois ED Kityo CMR Mugyenyi P 2004 Multiple validated measures of adherence indicate high levels of adherence to generic HIV antiretroviral therapy in a resource-limited setting J Acquir Immune Defic Syndr 36 1100 1102 15247564
  2. Oyugi JH Byakika-Tusiime J Ragland K Laeyendecker O Mugerwa R 2007 Treatment interruptions predict resistance in HIV-positive individuals purchasing fixed-dose combination antiretroviral therapy in Kampala, Uganda AIDS 21 965 971 17457090
  3. Byakika-Tusiime J Oyugi JH Tumwikirize WA Katabira ET Mugyenyi PN 2005 Adherence to HIV antiretroviral therapy in HIV+ Ugandan patients purchasing therapy Int J STD AIDS 16 38 41 15705271
  4. Weidle PJ Wamai N Solberg P Liechty C Sendagala S 2006 Adherence to antiretroviral therapy in a home-based AIDS care programme in rural Uganda Lancet 368 1587 1594 17084759
  5. Laurent C Ngom Gueye NF Ndour CT Gueye PM Diouf M 2005 Long-term benefits of highly active antiretroviral therapy in Senegalese HIV-1-infected adults J Acquir Immune Defic Syndr 38 14 17 15608518
  6. Daniel OJ Ogun SA Odusoga OL Falola RL Ogundahunsi OA 2004 Adherence pattern to ARV drugs among AIDS patients on self-purchased drugs and those on free medications in Sagamu, Nigeria Proceedings of the XV International AIDS Conference 11–16 July 2004; Bangkok, Thailand Abstract WePeB5786.
  7. Idoko JA Agbaji O Sankale JL Kanki P 2005 DOT-HAART in a resource limited setting: the use of community treatment support can be effective Proceedings of the 12th Conference on Retroviruses and Opportunistic Infections 22–25 February 2005; Boston, Massachusetts, United States Poster 629.
  8. Laurent C Kouanfack C Koulla-Shiro S Nkoue N Bourgeois A 2004 Effectiveness and safety of a generic fixed-dose combination of nevirapine, stavudine, and lamivudine in HIV-1-infected adults in Cameroon: open-label multicentre trial Lancet 364 29 34 15234853
  9. Weiser S Wolfe W Bangsberg D Thior I Gilbert P 2003 Barriers to antiretroviral adherence for patients living with HIV infection and AIDS in Botswana J Acquir Immune Defic Syndr 34 281 288 14600572
  10. Orrell C Bangsberg DR Badri M Wood R 2003 Adherence is not a barrier to successful antiretroviral therapy in South Africa AIDS 17 1369 1375 12799558
  11. Nachega JB Stein DM Lehman DA Hlathshwayo D Mothopeng R 2004 Adherence to antiretroviral therapy in HIV-infected adults in Soweto, South Africa AIDS Res Hum Retroviruses 20 1053 1056 15585095
  12. Mills EJ Nachega JB Buchan I Orbinski J Attaran A 2006 Adherence to antiretroviral therapy in sub-Saharan Africa and North America: a meta-analysis JAMA 296 679 690 16896111
  13. Harries AD Nyangulu DS Hargreaves NJ Kaluwa O Salaniponi FM 2001 Preventing antiretroviral anarchy in sub-Saharan Africa Lancet 358 410 414 11502341
  14. Popp D Fisher JD 2002 First do no harm: a call for emphasizing adherence and HIV prevention interventions in active antiretroviral therapy programs in the developing world AIDS 16 676 678 11873017
  15. Stevens W Kaye S Corrah T 2004 Antiretroviral therapy in Africa Br Med J 328 280 282 14751902 PMC324462
  16. Crane JT Kawuma A Oyugi JH Byakika JT Moss A 2006 The price of adherence: qualitative findings from HIV+ individuals purchasing fixed-dose combination generic HIV antiretroviral therapy in Kampala, Uganda AIDS Behav 10 437 442 16636892 PMC2386888
  17. Iliyasu Z Kabir M Abubakar IS Babashani M Zubair ZA 2005 Compliance to antiretroviral therapy among AIDS patients in Aminu Kano Teaching Hospital, Kano, Nigeria Niger J Med 14 290 294 16350700
  18. van Oosterhout JJ Bodasing N Kumwenda JJ Nyirenda C Mallewa J 2005 Evaluation of antiretroviral therapy results in a resource-poor setting in Blantyre, Malawi Trop Med Int Health 10 464 470 15860093
  19. Adedayo A Modupeola A Timothy A and HIV-positive adults 2005 Scaling-up antiretroviral therapy use for HIV-positive adults in Southwestern Nigeria Proceedings of the 12th Conference on Retroviruses and Opportunistic Infections 22–25 February 2005; Boston, Massachusetts, United States Poster No. 623.
  20. Hardon AP Akurut D Comoro C Ekezie C Irunde HF 2007 Hunger, waiting time and transport costs: time to confront challenges to ART adherence in Africa AIDS Care 19 658 665 17505927
  21. Mukherjee JS Ivers L Leandre E Farmer P Behforouz H 2006 Antiretroviral therapy in resource-poor settings: decreasing barriers to access and promoting adherence J Acquir Immune Defic Syndr 43 S123 S126 17133195
  22. Rosen S Ketlhapile M Sanne I DeSilva MB 2007 Cost to patients of obtaining treatment for HIV/AIDS in South Africa S Afr Med J 97 524 529 17805455
  23. Spacek LA Shihab HM Kamya MR Mwesigired D Ronald A 2006 Response to anti-retroviral therapy in HIV-infected patients attending a public, urban clinic in Kampala, Uganda Clin Infect Dis 42 252 259 16355337
  24. Eholie SP Tanon A Polneau S Ouiminga M Djadji A 2007 Field adherence to highly active antiretroviral therapy in HIV-infected adults in Abidjan, Cote d'Ivoire J Acquir Immune Defic Syndr 45 355 358 17438479
  25. Wanyama J Castelnuovo B Wandera B Mwebaze P Kambugu A 2007 Belief in divine healing can be a barrier to antiretroviral therapy adherence in Uganda AIDS 21 1486 1487 17589198
  26. Farmer P Leandre F Mukherjee J Gupta R Tarter L 2001 Community-based treatment of advanced HIV disease: introducing DOT-HAART (directly observed therapy with highly active antiretroviral therapy) Bull World Health Organ 79 1145 1151 11799447 PMC2566712
  27. Behforouz HL Farmer PE Mukherjee JS 2004 From directly observed therapy to accompagnateurs: enhancing AIDS treatment outcomes in Haiti and in Boston Clin Infect Dis 38 S429 S436 15156434
  28. Mukherjee JS Eustache FRE 2007 Community health workers as a cornerstone for integrating HIV and primary health care AIDS Care 19 Supplement 1 S73 S82 17364390
  29. Apondi R Bunnell R Awor A Wamai N Bikaako-Kajura W 2007 Home-based antiretroviral care is associated with positive social outcomes in a prospective cohort in Uganda J Acquir Immune Defic Syndr 44 71 76 17031319
  30. Nachega JB Knowlton AR Deluca A Schoeman JH Watkinson L 2006 Treatment supporter to improve adherence to antiretroviral therapy in HIV-infected South African adults: a qualitative study J Acquir Immune Defic Syndr (Supplement 1) S127 S133 17133196
  31. Taiwo BO Idoko J Otoh I Agbaji O Holoyda B 2008 Patient-selected treatment partner is associated with superior virologic response to first-line HAART in Jos, Nigeria 3rd International Conference on Treatment Adherence 17–18 March 2008; Jersey City, New Jersey, United States Available: http://www.iapac.org/AdherenceConference/AdherenceConfPrg_Links.pdf.
  32. Sarna A Luchters S Geibel S Chersich MF Munyao P 2008 Short- and long-term efficacy of modified directly observed antiretroviral treatment in Mombasa, Kenya: a randomized trial J Acquir Immune Defic Syndr 48 611 619 18645509
  33. Wohl AR Garland WH Valencia R Witt MD Squires K 2006 A randomized trial of directly administered antiretroviral therapy and adherence case management intervention Clin Infect Dis 42 1619 1627 16652320
  34. Altice FL Maru DS Bruce RD Springer SA Friedland GH 2007 Superiority of directly administered antiretroviral therapy over self-administered therapy among HIV-infected drug users: a prospective, randomized, controlled trial Clin Infect Dis 45 770 778 17712763 PMC2693907
  35. Creswell JW 1998 Qualitative inquiry and research design: choosing among five traditions Thousand Oaks (California) Sage Publications, Inc
  36. Strauss A Corbin J 1998 Basics of qualitative research: techniques and procedures for developing grounded theory Thousand Oaks (California) Sage Publications, Inc
  37. Cohen S Syme SL 1985 Social support and health Orlando (Florida) Academic Press
  38. Waxler-Morrison N Hislop TG Mears B Kan L 1991 Effect of social relationships on survival for women with breast cancer: a prospective study Soc Sci Med 33 177 183 1887281
  39. Uchino BN Cacioppo JT Kiecolt-Glaser JK 1996 The relationship between social support and physiological processes: a review with emphasis on underlying mechanisms and implications for health Psychol Bull 119 488 531 8668748
  40. Foster G 2007 Under the radar: community safety nets for AIDS-affected households in sub-Saharan Africa AIDS Care 19 54 63 17364388
  41. Fisher JD Fisher WA Amico KR Harman JJ 2006 An information-motivation-behavioral skills model of adherence to antiretroviral therapy Health Psychol 25 462 473 16846321
  42. Bourdieu P 1986 The forms of capital Richardson JE Handbook of theory of research for the sociology of education New York Greenwood Press 241 58
  43. Grootaert C van Bastelaer T Putnam R 2002 The role of social capital in development: an empirical assessment Cambridge and New York Cambridge University Press
  44. Castro A 2005 Adherence to antiretroviral therapy: merging the clinical and social course of AIDS PLoS Med 2 e338 doi: 10.1371/journal.pmed.0020338 16187735 PMC1240055 · DOI
  45. Nguyen VK Ako CY Niamba P Sylla A Tiendrebeogo I 2007 Adherence as therapeutic citizenship: impact of the history of access to antiretroviral drugs on adherence to treatment AIDS 21 S31 S35 18090265
  46. Livingston J 2005 Debility and the moral imagination in Botswana: disability, chronic illness, and aging Bloomington (Indiana) Indiana University Press

Cited by

Sorted by citations

Authors
Ware, N. C., Idoko, J., Kaaya, S., Biraro, I. A., Wyatt, M. A., Agbaji, O., Chalamilla, G., & Bangsberg, D. R.
Affiliations
  • Harvard University (US)
  • University of Jos (NG)
  • Muhimbili University of Health and Allied Sciences (TZ)
  • Mbarara University of Science and Technology (UG)
Corresponding author
Ware, Norma C
Venue
PLoS Medicine
Published
2009-01-27
Volume
6
Issue
1
Pages
e1000011
ISSN
  • 1549-1277 (ISSN-L)
  • 1549-1676
OpenAlex
W2119740264
Cited by
437
References
6
Citations by year
2026: 29 · 2025: 9 · 2024: 12 · 2023: 7 · 2022: 14 · 2021: 14 · 2020: 17 · 2019: 21 · 2018: 29 · 2017: 22 · 2016: 37 · 2015: 16 · 2014: 33 · 2013: 50 · 2012: 35
FWCI
28.98
Type
journal article
Language
en
Open access
Locations
  • PLoS Medicine (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • IHI Repository (acceptedVersion)
  • Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
  • RePEc: Research Papers in Economics (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Harvard University
  • Muhimbili University of Health and Allied Sciences
  • University of Health and Allied Sciences
  • National Institutes of Health (5k24aa015287-03)
  • National Institute on Alcohol Abuse and Alcoholism (K-24 AA015287)
  • National Institute of Mental Health (R01MH054907, R21MH077539)
Topics
  • Health Sciences › Medicine › Infectious Diseases › HIV/AIDS Research and Interventions
  • Health Sciences › Medicine › Family Practice › Medication Adherence and Compliance
  • Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › HIV/AIDS Impact and Responses
Keywords
antiretroviral therapy adherence, HIV/AIDS, social capital, social responsibility, financial barriers to treatment, resource allocation, social support, social networks, poverty, sub-Saharan Africa
MeSH terms
Acquired Immunodeficiency Syndrome, Adult, Anthropology, Cultural, Female, Humans, Interviews as Topic, Male, Patient Compliance, Social Support, Socioeconomic Factors, Health Care Costs, Africa South of the Sahara, Anti-Retroviral Agents

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review